QSAR modeling and transmission electron microscopy stereology of altered mitochondrial ultrastructure of white blood cells in patients diagnosed as schizophrenic and treated with antipsychotic drugs.
Treatment of patients diagnosed as schizophrenic with antipsychotic drugs (neuroleptics) is known to cause occasional unexplained depletion of white blood cells, especially neutrophil granulocytes. It has been known for many years that neuroleptics can interfere with the mitochondrial respiratory chain in vitro. Because there has been a growing interest recently in mitochondrial targeting of drugs, and since a quantitative structure-activity relationship (QSAR) model that predicts mitochondrial accumulation of neuroleptics has been published, we investigated the effects of neuroleptics on white blood cell mitochondria. Venous blood samples were collected from both patients undergoing treatment with neuroleptics and healthy volunteers. The samples were processed for transmission electron microscopy. The resulting images of white blood cells were analyzed using stereology to compare quantitatively mitochondrial morphology in the patient and control groups. We found that in patients, but not in controls, there was swelling of mitochondria and fragmentation of the mitochondrial cristae. There also were fewer mitochondria in patients than in controls, although due to the swelling of the organelles, the volume density of mitochondria in the two groups was not significantly different. Such changes are typical of a toxic insult. Consequently, it seems plausible that, since schizophrenia is not a disease considered to affect white blood cells per se, these changes probably are due to the medication.
Inuwa
I M
IM
Department of Human and Clinical Anatomy, Sultan Qaboos University, PO Box 35, Al Khod 123, Muscat, Sultanate of Oman. ibrahim1@squ.edu.om
Peet
M
M
Williams
M A
MA
D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics*; D003198:Computer Simulation; D006801:Humans; D021621:Imaging, Three-Dimensional; D007962:Leukocytes / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure*; D046529:Microscopy, Electron, Transmission; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure*; D008954:Models, Biological; D008956:Models, Chemical; D021281:Quantitative Structure-Activity Relationship; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology*; D016896:Treatment Outcome
D014150:Antipsychotic Agents